Clinical Chemistry

Article	Citations
Rapid Detection of COVID-19 Coronavirus Using a Reverse Transcriptional Loop-Mediated Isothermal Amplification (RT-LAMP) Diagnostic Platform	309
The Digital MIQE Guidelines Update: Minimum Information for Publication of Quantitative Digital PCR Experiments for 2020	241
Potential False-Negative Nucleic Acid Testing Results for Severe Acute Respiratory Syndrome Coronavirus 2 from Thermal Inactivation of Samples with Low Viral Loads	181
Rapid and Extraction-Free Detection of SARS-CoV-2 from Saliva by Colorimetric Reverse-Transcription Loop-Mediated Isothermal Amplification	160
Inflammation in Atherosclerosis—No Longer a Theory	158
Clinical Performance of Two SARS-CoV-2 Serologic Assays	158
Ultra-Sensitive Serial Profiling of SARS-CoV-2 Antigens and Antibodies in Plasma to Understand Disease Progression in COVID-19 Patients with Severe Disease	130
Residual Cardiovascular Risk at Low LDL: Remnants, Lipoprotein(a), and Inflammation	122
Association between SARS-CoV-2 Neutralizing Antibodies and Commercial Serological Assays	106
Limits of Detection of 6 Approved RT–PCR Kits for the Novel SARS-Coronavirus-2 (SARS-CoV-2)	106
Lipoprotein(a) and Cardiovascular Disease	104
Side-by-Side Comparison of Three Fully Automated SARS-CoV-2 Antibody Assays with a Focus on Specificity	96
Clinical Performance of the Elecsys Electrochemiluminescent Immunoassay for the Detection of SARS-CoV-2 Total Antibodies	96
Rapid Detection of SARS-CoV-2 by Low Volume Real-Time Single Tube Reverse Transcription Recombinase Polymerase Amplification Using an Exo Probe with an Internally Linked Quencher (Exo-IQ)	95
SARS-CoV-2 Serology: Much Hype, Little Data	83
Routine Laboratory Blood Tests Predict SARS-CoV-2 Infection Using Machine Learning	75
Investigational Biomarkers for Checkpoint Inhibitor Immune-Related Adverse Event Prediction and Diagnosis	69
National Kidney Foundation Laboratory Engagement Working Group Recommendations for Implementing the CKD-EPI 2021 Race-Free Equations for Estimated Glomerular Filtration Rate: Practical Guidance for Cl	69
Evaluation of High-Throughput SARS-CoV-2 Serological Assays in a Longitudinal Cohort of Patients with Mild COVID-19: Clinical Sensitivity, Specificity, and Association with Virus Neutralization Test	62
The Role of Metagenomics and Next-Generation Sequencing in Infectious Disease Diagnosis	61
Metagenomic Analysis Reveals Clinical SARS-CoV-2 Infection and Bacterial or Viral Superinfection and Colonization	61
Generic Protocols for the Analytical Validation of Next-Generation Sequencing-Based ctDNA Assays: A Joint Consensus Recommendation of the BloodPAC’s Analytical Variables Working Group	59
Triglyceride-Rich Lipoprotein Remnants and Cardiovascular Disease	58
Clinical Performance of the Roche SARS-CoV-2 Serologic Assay	58
Clinical Evaluation of an Improved Metagenomic Next-Generation Sequencing Test for the Diagnosis of Bloodstream Infections	54

Commercial Serology Assays Predict Neutralization Activity against SARS-CoV-2	51
Clinical Impact of the Refit CKD-EPI 2021 Creatinine-Based eGFR Equation	49
Antibody Profiles in Mild and Severe Cases of COVID-19	48
Towards an SI-Traceable Reference Measurement System for Seven Serum Apolipoproteins Using Bottom-Up Quantitative Proteomics: Conceptual Approach Enabled by Cross-Disciplinary/Cross-Sector Collaborati	48
Lateral Flow Assays in Infectious Disease Diagnosis	46
Cautionary Note on Contamination of Reagents Used for Molecular Detection of SARS-CoV-2	46
Personalized Reference Intervals in Laboratory Medicine: A New Model Based on Within-Subject Biological Variation	45
Myocardial Injury and the Release of Troponins I and T in the Blood of Patients	44
Efficiency Correction Is Required for Accurate Quantitative PCR Analysis and Reporting	42
Neural Antibody Testing in Patients with Suspected Autoimmune Encephalitis	41
The Dangers of Using Cq to Quantify Nucleic Acid in Biological Samples: A Lesson From COVID-19	40
A New Equation Based on the Standard Lipid Panel for Calculating Small Dense Low-Density Lipoprotein-Cholesterol and Its Use as a Risk-Enhancer Test	39
Development of an LC-MS/MS Proposed Candidate Reference Method for the Standardization of Analytical Methods to Measure Lipoprotein(a)	38
Plasma or Serum: Which Is Preferable for Mutation Detection in Liquid Biopsy?	38
SARS-CoV-2 Nucleocapsid Plasma Antigen for Diagnosis and Monitoring of COVID-19	36
Diagnostic Value of Nucleocapsid Protein in Blood for SARS-CoV-2 Infection	36
Programmed Cell Death Ligand 1-Expressing Circulating Tumor Cells: A New Prognostic Biomarker in Non-Small Cell Lung Cancer	35
Clinical Correlations of Programmed Cell Death Ligand 1 Status in Liquid and Standard Biopsies in Breast Cancer	33
Detection of ctDNA from Dried Blood Spots after DNA Size Selection	32
Noninvasive Fetal Genotyping by Droplet Digital PCR to Identify Maternally Inherited Monogenic Diabetes Variants	32
Verification of Harmonization of Serum Total and Free Prostate-Specific Antigen (PSA) Measurements and Implications for Medical Decisions	32
Choline Metabolism and Risk of Atrial Fibrillation and Heart Failure in the PREDIMED Study	31
Understanding Patient-Based Real-Time Quality Control Using Simulation Modeling	30
Forever Connected: The Lifelong Biological Consequences of Fetomaternal and Maternofetal Microchimerism	29
Sex Differences in Cardiac Troponin I and T and the Prediction of Cardiovascular Events in the General Population	29
Serum Prostate-Specific Antigen Testing for Early Detection of Prostate Cancer: Managing the Gap between Clinical and Laboratory Practice	29
SARS-CoV-2 Whole Genome Amplification and Sequencing for Effective Population-Based Surveillance and Control of Viral Transmission	29
Quantification of Human Epidermal Growth Factor Receptor 2 by Immunopeptide Enrichment and Targeted Mass Spectrometry in Formalin-Fixed Paraffin-Embedded and Frozen Breast Cancer Tissues	29
Getting Cardiac Troponin Right: Appraisal of the 2020 European Society of Cardiology Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elev	27
Navigating Clinical Utilization of Direct-from-Specimen Metagenomic Pathogen Detection: Clinical Applications, Limitations, and Testing Recommendations	27
Emerging Fungal Infections: New Species, New Names, and Antifungal Resistance	27
Molecular and Serological Assays for SARS-CoV-2: Insights from Genome and Clinical Characteristics	26
Analytical Considerations in Deriving 99th Percentile Upper Reference Limits for High-Sensitivity Cardiac Troponin Assays: Educational Recommendations from the IFCC Committee on Clinical Application o	26
Characteristics of Fetal Extrachromosomal Circular DNA in Maternal Plasma: Methylation Status and Clearance	26
High-Sensitivity Cardiac Troponin T for the Detection of Myocardial Injury and Risk Stratification in COVID-19	26
Evolving Applications of Artificial Intelligence and Machine Learning in Infectious Diseases Testing	26
Assessment of Multiplex Digital Droplet RT-PCR as a Diagnostic Tool for SARS-CoV-2 Detection in Nasopharyngeal Swabs and Saliva Samples	26
Multiple Myeloma Minimal Residual Disease Detection: Targeted Mass Spectrometry in Blood vs Next-Generation Sequencing in Bone Marrow	25
Performance of a Paired-End Sequencing-Based Noninvasive Prenatal Screening Test in the Detection of Genome-Wide Fetal Chromosomal Anomalies	25
Obesity and Kidney Function: A Two-Sample Mendelian Randomization Study	25
Proficiency Testing to Assess Technical Performance for CTC-Processing and Detection Methods in CANCER-ID	25
Digital Microfluidic Hemagglutination Assays for Blood Typing, Donor Compatibility Testing, and Hematocrit Analysis	24
Targeted-Sequencing Workflows for Comprehensive Drug Resistance Profiling of Mycobacterium tuberculosis Cultures Using Two Commercial Sequencing Platforms: Comparison of Analytical and Diagnostic Perf	24
Triglycerides as a Shared Risk Factor between Dementia and Atherosclerotic Cardiovascular Disease: A Study of 125 727 Individuals	24
Artificial Intelligence and Mapping a New Direction in Laboratory Medicine: A Review	24
Time-Dependent Apparent Increase in dd-cfDNA Percentage in Clinically Stable Patients Between One and Five Years Following Kidney Transplantation	24
Prognostic Value of Novel Liquid Biomarkers in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide: A Prospective Observational Study	24
Genomic Prediction of Antimicrobial Resistance: Ready or Not, Here It Comes!	24
Clinical Application of Multiple Reaction Monitoring-Mass Spectrometry to Human Epidermal Growth Factor Receptor 2 Measurements as a Potential Diagnostic Tool for Breast Cancer Therapy	23
Jagged Ends of Urinary Cell-Free DNA: Characterization and Feasibility Assessment in Bladder Cancer Detection	23

Implementation of High-Sensitivity and Point-of-Care Cardiac Troponin Assays into Practice: Some Different Thoughts	23
Single-Molecule Sequencing Enables Long Cell-Free DNA Detection and Direct Methylation Analysis for Cancer Patients	23
Comprehensive Analysis of Congenital Adrenal Hyperplasia Using Long-Read Sequencing	23
Preparedness and Rapid Implementation of External Quality Assessment Helped Quickly Increase COVID-19 Testing Capacity in the Republic of Korea	23
99th Percentile Upper-Reference Limit of Cardiac Troponin and the Diagnosis of Acute Myocardial Infarction	22
The Truth about SARS-CoV-2 Cycle Threshold Values Is Rarely Pure and Never Simple	22
Measurement of Serum Neuron-Specific Enolase in Neuroblastoma: Is There a Clinical Role?	22
Standardized Workflow for Precise Mid- and High-Throughput Proteomics of Blood Biofluids	22
Biological Variation of Cardiac Troponins in Health and Disease: A Systematic Review and Meta-analysis	21
Assessing the Accuracy and Clinical Utility of ChatGPT in Laboratory Medicine	21
Ultra-Early Differential Diagnosis of Acute Cerebral Ischemia and Hemorrhagic Stroke by Measuring the Prehospital Release Rate of GFAP	21
Circulating Ceramides and Sphingomyelins and Risk of Mortality: The Cardiovascular Health Study	21
IFCC Working Group Recommendations for Correction of Bias Caused by Noncommutability of a Certified Reference Material Used in the Calibration Hierarchy of an End-User Measurement Procedure	21
Analytical Sensitivity and Specificity of Four Point of Care Rapid Antigen Diagnostic Tests for SARS-CoV-2 Using Real-Time Quantitative PCR, Quantitative Droplet Digital PCR, and a Mass Spectrometric	21
A Highly Automated Mobile Laboratory for On-site Molecular Diagnostics in the COVID-19 Pandemic	21
Cell-Free DNA as Biomarker for Sepsis by Integration of Microbial and Host Information	20
Nanopore Identification of Single Nucleotide Mutations in Circulating Tumor DNA by Multiplexed Ligation	20
Cardiac Troponin Testing in Patients with COVID-19: A Strategy for Testing and Reporting Results	20
Plasma S100A8/A9 Concentrations and Clinical Outcomes of Ischemic Stroke in 2 Independent Multicenter Cohorts	20
AACC Practical Recommendations for Implementing and Interpreting SARS-CoV-2 Emergency Use Authorization and Laboratory-Developed Test Serologic Testing in Clinical Laboratories	19
Growth Differentiation Factor (GDF)-15 and Cardiometabolic Outcomes among Older Adults: The Atherosclerosis Risk in Communities Study	19
SwabExpress: An End-to-End Protocol for Extraction-Free COVID-19 Testing	19
How Can We Ensure Reproducibility and Clinical Translation of Machine Learning Applications in Laboratory Medicine?	19
Distinguishing Non-Small Cell Lung Cancer Subtypes in Fine Needle Aspiration Biopsies by Desorption Electrospray Ionization Mass Spectrometry Imaging	19
The Vitamin D Metabolite Ratio Is Independent of Vitamin D Binding Protein Concentration	19
Development of a Plasma Biomarker Diagnostic Model Incorporating Ultrasensitive Digital Immunoassay as a Screening Strategy for Alzheimer Disease in a Chinese Population	19
25-Hydroxyvitamin D and Risk of Osteoporotic Fractures: Mendelian Randomization Analysis in 2 Large Population-Based Cohorts	19
Genome-Scale Methylation Analysis of Circulating Cell-Free DNA in Gastric Cancer Patients	18
Method-Specific Cortisol and Dexamethasone Thresholds Increase Clinical Specificity of the Dexamethasone Suppression Test for Cushing Syndrome	18
Cell-Free DNA Fragmentomics: The New “Omics” on the Block	18
Harmonization of LC-MS/MS Measurements of Plasma Free Normetanephrine, Metanephrine, and 3-Methoxytyramine	18
Type 2 Myocardial Infarction: Evolving Approaches to Diagnosis and Risk-Stratification	18
Circulating Tumor DNA as a Biomarker for Monitoring Patients with Solid Cancers: Comparison with Standard Protein Biomarkers	17
Diagnostic Performance of Metagenomic Next-Generation Sequencing in Pediatric Patients: A Retrospective Study in a Large Children’s Medical Center	17
Analytical Performance Specifications for Lipoprotein(a), Apolipoprotein B-100, and Apolipoprotein A-I Using the Biological Variation Model in the EuBIVAS Population	17
Development of Label-Free Immunoassays as Novel Solutions for the Measurement of Monoclonal Antibody Drugs and Antidrug Antibodies	17
Single-Cell Identification, Drug Susceptibility Test, and Whole-genome Sequencing of Helicobacter pylori Directly from Gastric Biopsy by Clinical Antimicrobial Susceptibility Test Ramanometry	17
Glycated Albumin for the Diagnosis of Diabetes in US Adults	17
Regression-Adjusted Real-Time Quality Control	17
RIbench: A Proposed Benchmark for the Standardized Evaluation of Indirect Methods for Reference Interval Estimation	17
Whole-Transcriptome Analysis by RNA Sequencing for Genetic Diagnosis of Mendelian Skin Disorders in the Context of Consanguinity	17
Evaluation of Orthogonal Testing Algorithm for Detection of SARS-CoV-2 IgG Antibodies	17
Chemical Characterization and Quantification of Circulating Intact PTH and PTH Fragments by High-Resolution Mass Spectrometry in Chronic Renal Failure	17
Comparison of Single Molecule, Real-Time Sequencing and Nanopore Sequencing for Analysis of the Size, End-Motif, and Tissue-of-Origin of Long Cell-Free DNA in Plasma	16
Optimizing the Use of High-Sensitivity Troponin Assays for the Early Rule-out of Myocardial Infarction in Patients Presenting with Chest Pain: A Systematic Review	16
Metabolomics in Clinical Practice: Improving Diagnosis and Informing Management	16
Choice of Statistical Tools for Outlier Removal Causes Substantial Changes in Analyte Reference Intervals in Healthy Populations	16
Very Low-Density Lipoprotein Cholesterol May Mediate a Substantial Component of the Effect of Obesity on Myocardial Infarction Risk: The Copenhagen General Population Study	16
Plasma Glial Fibrillary Acidic Protein in the Alzheimer Disease Continuum: Relationship to Other Biomarkers, Differential Diagnosis, and Prediction of Clinical Progression	16
Identifying Optimal Loci for the Molecular Diagnosis of Microsatellite Instability	15
Development and Analytical Validation of a Reverse Transcription Droplet Digital PCR (RT-ddPCR) Assay forPD-L1Transcripts in Circulating Tumor Cells	15
The Effect of Preanalytical and Physiological Variables on Cell-Free DNA Fragmentation	15
Circular RNA Sequencing Reveals Serum Exosome Circular RNA Panel for High-Grade Astrocytoma Diagnosis	15
Overinterpretation of Research Findings: Evaluation of “Spin” in Systematic Reviews of Diagnostic Accuracy Studies in High–Impact Factor Journals	15
Biomarkers for Risk Assessment in Atrial Fibrillation	15
Urinary Metabolite Biomarkers for the Detection of Synthetic Cannabinoid ADB-BUTINACA Abuse	14
Glycated Albumin and Risk of Mortality in the US Adult Population	14
Giant Magnetoresistive Nanosensor Analysis of Circulating Tumor DNA Epidermal Growth Factor Receptor Mutations for Diagnosis and Therapy Response Monitoring	14
Optimizing Available Tools for Achieving Result Standardization: Value Added by Joint Committee on Traceability in Laboratory Medicine (JCTLM)	14
Biomarkers and Clinical Laboratory Detection of Acute and Chronic Ethanol Use	14
A Collaborative Effort to Define Classification Criteria forATMVariants in Hereditary Cancer Patients	14
Sample Multiplexing: Increased Throughput for Quantification of Total Testosterone in Serum by Liquid Chromatography-Tandem Mass Spectrometry	14
HDL in Morbidity and Mortality: A 40+ Year Perspective	14
ApoB vs non-HDL-C vs LDL-C as Markers of Cardiovascular Disease	14
Mass Spectrometry for COVID-19	14
High-Throughput CRISPR–Cas13 SARS-CoV-2 Test	14
The European Biological Variation Study (EuBIVAS): Biological Variation Data for Coagulation Markers Estimated by a Bayesian Model	14
Recent Advances in Rapid Antimicrobial Susceptibility Testing	14
Cardiac Biomarkers in Pediatrics: An Undervalued Resource	13
Validation of an LC-MS/MS Method Using Solid-Phase Extraction for the Quantification of 1-84 Parathyroid Hormone: Toward a Candidate Reference Measurement Procedure	13
Evaluation of Sperm DNA Integrity by Mean Number of Sperm DNA Breaks Rather Than Sperm DNA Fragmentation Index	13
Atrial Fibrillation and the Prognostic Performance of Biomarkers in Heart Failure	13
Empiricism in Microsampling: Utilizing a Novel Lateral Flow Device and Intrinsic Normalization to Provide Accurate and Precise Clinical Analysis from a Finger Stick	13
Utility of Circulating Free DNA Fragmentomics in the Prediction of Pathological Response after Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer	13
What Is Extrachromosomal Circular DNA and What Does It Do?	13
Variability of “Reported Fetal Fraction” in Noninvasive Prenatal Screening (NIPS)	13
Associations of Cardiac, Kidney, and Diabetes Biomarkers With Peripheral Neuropathy among Older Adults in the Atherosclerosis Risk in Communities (ARIC) Study	13
Achieving Expert-Level Interpretation of Serum Protein Electrophoresis through Deep Learning Driven by Human Reasoning	13
Long-Term Longitudinal Stability of Kidney Filtration Marker Measurements: Implications for Epidemiological Studies and Clinical Care	13
Interoperability: COVID-19 as an Impetus for Change	13

Current State of Laboratory Automation in Clinical Microbiology Laboratory	13
Multiplex PCR and Nanopore Sequencing of Genes Associated with Antimicrobial Resistance in Neisseria gonorrhoeae Directly from Clinical Samples	12
Data Mining Approaches to Reference Interval Studies	12
Comprehensive Analysis of Fragile X Syndrome: Full Characterization of the FMR1 Locus by Long-Read Sequencing	12
Early Rule-Out Strategies in the Emergency Department Utilizing High-Sensitivity Cardiac Troponin Assays	12
Enhanced Performance of DNA Methylation Markers by Simultaneous Measurement of Sense and Antisense DNA Strands after Cytosine Conversion	12
Laboratory-Developed Tests in the New European Union 2017/746 Regulation: Opportunities and Risks	12
Breath Metabolites to Diagnose Infection	12
Prognostic Value of Programmed Cell Death-Ligand 1 Expression in Tumor-Infiltrating Lymphocytes and Viral Load in Peripheral Blood Mononuclear Cells for Epstein–Barr Virus–Positive Nasopharyngeal Carc	12
Circulating Cell-Free DNA Yield and Circulating-Tumor DNA Quantity from Liquid Biopsies of 12 139 Cancer Patients	12
A Comprehensive Molecular Analysis of in Vivo Isolated EpCAM-Positive Circulating Tumor Cells in Breast Cancer	12
Elementary Overview of Heavy Metals	12
Evaluation of Neutralizing Antibodies against SARS-CoV-2 Variants after Infection and Vaccination Using a Multiplexed Surrogate Virus Neutralization Test	12
Single-Cell Phenotypic and Molecular Characterization of Circulating Tumor Cells Isolated from Cryopreserved Peripheral Blood Mononuclear Cells of Patients with Lung Cancer and Sarcoma	11
Serial Circulating Tumor DNA Mutational Status in Patients with KRAS-Mutant Metastatic Colorectal Cancer from the Phase 3 AIO KRK0207 Trial	11
Plasma Ionized Calcium and Risk of Cardiovascular Disease: 106 774 Individuals from the Copenhagen General Population Study	11
Harmonization Status of Serum Ferritin Measurements and Implications for Use as Marker of Iron-Related Disorders	11
Comparison of Proteomic Measurements Across Platforms in the Atherosclerosis Risk in Communities (ARIC) Study	11
Toward Clinical Application of Leukocyte Counts Based on Targeted DNA Methylation Analysis	11
Diagnostic Stewardship in Clinical Microbiology, Essential Partner to Antimicrobial Stewardship	11
Sex-Specific Kinetics of High-Sensitivity Cardiac Troponin I and T following Symptom Onset and Early Presentation in Non-ST-Segment Elevation Myocardial Infarction	11
Interpreting EQA—Understanding Why Commutability of Materials Matters	11
Type I Interferon in Children with Viral or Bacterial Infections	11
A Translational Tool to Facilitate Use of Apolipoprotein B for Clinical Decision-Making	11
Development of an LC-MRM-MS-Based Candidate Reference Measurement Procedure for Standardization of Serum Apolipoprotein (a) Tests	11
Clonotypic Features of Rearranged Immunoglobulin Genes Yield Personalized Biomarkers for Minimal Residual Disease Monitoring in Multiple Myeloma	11
TOP-Plus Is a Versatile Biosensor Platform for Monitoring SARS-CoV-2 Antibody Durability	11
Multiplex Detection of Clinically Relevant Mutations in Liquid Biopsies of Cancer Patients Using a Hybridization-Based Platform	11
Urinary Cell-Free DNA in Liquid Biopsy and Cancer Management	10
Prognostic Metrics Associated with Inflammation and Atherosclerosis Signaling Evaluate the Burden of Adverse Clinical Outcomes in Ischemic Stroke Patients	10
Dutch National Round Robin Trial on Plasma-Derived Circulating Cell-Free DNA Extraction Methods Routinely Used in Clinical Pathology for Molecular Tumor Profiling	10
Metabolomic Fingerprints in Large Population Cohorts: Impact of Preanalytical Heterogeneity	10
Uncertainty in Estimated Glomerular Filtration Rate Is Much Larger than the Race Adjustment Term	10
Patient-Based Real Time QC	10
Ultrasensitive DNA Immune Repertoire Sequencing Using Unique Molecular Identifiers	10
Diagnostic Validation of a High-Sensitivity Cardiac Troponin I Assay	10
An Update on Laboratory-Based Diagnostic Biomarkers for Multiple Sclerosis and Beyond	10
Relative Efficacy of Different Strategies for Inhibition of in Vitro Glycolysis	10
Analytical and Clinical Validation of Cell-Free Circulating Tumor DNA Assay for the Estimation of Tumor Mutational Burden	10
Detection of Circulating Tumor Cells in Cerebrospinal Fluid of Patients with Suspected Breast Cancer Leptomeningeal Metastases: A Prospective Study	10
Direct Water-Assisted Laser Desorption/Ionization Mass Spectrometry Lipidomic Analysis and Classification of Formalin-Fixed Paraffin-Embedded Sarcoma Tissues without Dewaxing	10
Identifying Clinically Relevant Bacteria Directly from Culture and Clinical Samples with a Handheld Mass Spectrometry Probe	10
Limited Evidence for Use of a Black Race Modifier in eGFR Calculations: A Systematic Review	10
Clinical Translation and Evaluation of a Handheld and Biocompatible Mass Spectrometry Probe for Surgical Use	10
Next-Generation Sequencing–Based Analysis of Urine Cell-Free mtDNA Reveals Aberrant Fragmentation and Mutation Profile in Cancer Patients	9
Macrotroponin Complex as a Cause for Cardiac Troponin Increase after COVID-19 Vaccination and Infection	9
Role of Cardiac Biomarkers in Epidemiology and Risk Outcomes	9
Deep Convolutional Neural Networks Implementation for the Analysis of Urine Culture	9
Breast Cancer Detection and Treatment Monitoring Using a Noninvasive Prenatal Testing Platform: Utility in Pregnant and Nonpregnant Populations	9
Guidance on Which Calibrators in a Metrologically Traceable Calibration Hierarchy Must Be Commutable with Clinical Samples	9
Evaluating the Clinical Utility of a Long-Read Sequencing-Based Approach in Prenatal Diagnosis of Thalassemia	9
Average of Patient Deltas: Patient-Based Quality Control Utilizing the Mean Within-Patient Analyte Variation	9
Neutral-Coating Capillary Electrophoresis Coupled with High-Resolution Mass Spectrometry for Top-Down Identification of Hemoglobin Variants	9
Microbial Taxonomy: How and Why Name Changes Occur and Their Significance for (Clinical) Microbiology	9
LIPCAR Is Increased in Chronic Symptomatic HF Patients. A Sub-Study of the GISSI-HF Trial	9
Measurement of Immature Reticulocytes in Dried Blood Spots by Mass Spectrometry	9
Improving Harmonization and Standardization of Expanded Newborn Screening Results by Optimization of the Legacy Flow Injection Analysis Tandem Mass Spectrometry Methods and Application of a Standardiz	9
Digital Quantification of Chemical Oligonucleotide Synthesis Errors	9
High Speed Centrifugation Before Frozen Storage of Plasma Is Critical for Quantitative Analysis of Mitochondrial-Derived Cell-Free DNA	9
Multiplex Fragment Analysis for Flexible Detection of All SARS-CoV-2 Variants of Concern	9
Clinical Decision Support for Laboratory Testing	9
Case-Control Study of Individuals with Discrepant Nucleocapsid and Spike Protein SARS-CoV-2 IgG Results	9
Effect of Macrotroponin in a Cohort of Community Patients with Elevated Cardiac Troponin	9
Liquid Biopsy and Immuno-Oncology for Advanced Nonsmall Cell Lung Cancer	8
Applications of Digital Microscopy and Densely Connected Convolutional Neural Networks for Automated Quantification of Babesia-Infected Erythrocytes	8
Angiogenic Biomarkers for Risk Stratification in Women with Preeclampsia	8
CRISPR Cas9-Mediated Selective Isothermal Amplification for Sensitive Detection of Rare Mutant Alleles	8
Machine Learning in Laboratory Medicine: Recommendations of the IFCC Working Group	8
Evaluation of Three Commercial Automated Assays for the Detection of Anti-SARS-CoV-2 Antibodies	8
Prognostic Value of Low-Pass Whole Genome Sequencing of Circulating Tumor DNA in Metastatic Castration-Resistant Prostate Cancer	8
At-Home Testing for Infectious Diseases: The Laboratory Where You Live	8
Optimized Droplet Digital PCR Assay on Cell-Free DNA Samples for Non-Invasive Prenatal Diagnosis: Application to Beta-Thalassemia	8
High-Sensitivity Single Molecule Array Assays for Pathological Isoforms in Parkinson’s Disease	8
Single Cell and Plasma RNA Sequencing for RNA Liquid Biopsy for Hepatocellular Carcinoma	8
Recognition of the Prehospital Preanalytical Phase: Collaborative Efforts between Laboratory Medicine and Emergency Medicine to Ensure Quality Testing	8
Combining First and Second-Tier Newborn Screening in a Single Assay Using High-Throughput Chip-Based Capillary Electrophoresis Coupled to High-Resolution Mass Spectrometry	8
Femtomolar SARS-CoV-2 Antigen Detection Using the Microbubbling Digital Assay with Smartphone Readout Enables Antigen Burden Quantitation and Tracking	8
The Present and Future of Lipid Testing in Cardiovascular Risk Assessment	8
Erratum: The Digital MIQE Guidelines Update: Minimum Information for Publication of Quantitative Digital PCR Experiments for 2020	8
Ceramides and Phosphatidylcholines Associate with Cardiovascular Diseases in the Elderly	8
A Machine Learning Approach for the Automated Interpretation of Plasma Amino Acid Profiles	8
Causal Relationship between Plasma Adiponectin and Body Mass Index: One- and Two-Sample Bidirectional Mendelian Randomization Analyses in 460 397 Individuals	8
Plasma Clearance of B-Type Natriuretic Peptide (BNP) before and after Bariatric Surgery for Morbid Obesity	8
Challenges in Translating Clinical Metabolomics Data Sets from the Bench to the Bedside	8
Use of Racial and Ethnic Categories in Medical Testing and Diagnosis: Primum Non Nocere	8
Plasma Concentrations of Magnesium and Risk of Dementia: A General Population Study of 102 648 Individuals	8
New Sampson Low-Density Lipoprotein Equation: Better Than Friedewald and Martin-Hopkins	8
Error Characterization and Statistical Modeling Improves Circulating Tumor DNA Detection by Droplet Digital PCR	8
Cardiovascular Disease in Women: Understanding the Journey	8
Circulating Cell-Free Mitochondrial DNA in Cerebrospinal Fluid as a Biomarker for Mitochondrial Diseases	7
Liquid Biopsy Hotspot Variant Assays: Analytical Validation for Application in Residual Disease Detection and Treatment Monitoring	7
Galaxy Is a Suitable Bioinformatics Platform for the Molecular Diagnosis of Human Genetic Disorders Using High-Throughput Sequencing Data Analysis: Five Years of Experience in a Clinical Laboratory	7
A Three-Site Immunoassay for High-Sensitivity Cardiac Troponin I with Low Immunoreactivity for Macrocomplexes	7
Sex-Specific 99th Percentile URLs for Cardiac Troponin Assays—Their Time Has Come	7
Commutability Assessment of Candidate Reference Materials for Lipoprotein(a) by Comparison of a MS-based Candidate Reference Measurement Procedure with Immunoassays	7